Trials / Conditions / Familial Partial Lipodystrophy

Familial Partial Lipodystrophy

9 registered clinical trials studyying Familial Partial Lipodystrophy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic NCT07412028	Assistance Publique - Hôpitaux de Paris	N/A
Recruiting	Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy NCT06679270	Amryt Pharma	Phase 3
Terminated	A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With NCT05088460	Regeneron Pharmaceuticals	Phase 2
Completed	Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) NCT03514420	Akcea Therapeutics	Phase 2
Completed	Study of Gemcabene in Adults With FPLD NCT03508687	Elif Oral	Phase 1 / Phase 2
Completed	Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients NCT02430077	Abhimanyu Garg	Phase 2
Terminated	The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Li NCT02527343	Akcea Therapeutics	Phase 2 / Phase 3
Completed	CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial NCT02654977	University of Michigan	Phase 2
Available	Expanded Access Metreleptin Study NCT02404896	University of Michigan	—